Over the past 5 years, results from several large clinical trials on SGLT2 inhibitors have been published (30, 3238) (see Table 1), and the expectation for OHAs has gradually changed from cardiovascular safety to cardiovascular benefits. Among the renal outcome studies, EMPA-REG OUTCOME was the first to report a 39% reduction in the risk of developing a renal composite endpoint with empagliflozin, suggesting that empagliflozin may delay the progression of renal diseases (39)
Both regimens led to a rapid rise in vitamin B12 and holoTC concentrations, and a normalization of elevated MMA and tHcy levels
It supports the maintenance of skin's natural functions by aiding in the visible improvement of skin texture and elasticity
Among all the active GLP-1R structures, H363 6.52b dipped into the TMD core whereas it is reoriented ~90 to an outside-facing position and formed a hydrogen bond with Q394 7.49b through dismissal of the hydrogen bond with the backbone carbonyl oxygen atom of P358 6.47b
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer